CCCC logo

C4 Therapeutics (CCCC) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$55.50 M
-$71.09 M-56.16%

December 1, 2024


Summary


Performance

CCCC Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCCCCbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$55.50 M
-$4.15 M-6.96%

December 31, 2024


Summary


Performance

CCCC Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCCCCbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

CCCC Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-56.2%-7.0%
3 y3 years-27.1%-7.0%
5 y5 years-38.7%-7.0%

CCCC Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-56.2%+86.5%-56.2%+86.5%
5 y5-year-69.5%+86.5%-80.3%+86.5%
alltimeall time-69.5%+86.5%-80.3%+86.5%

C4 Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
-
$55.50 M(-7.0%)
Dec 2024
$55.50 M(-56.2%)
-
Sep 2024
-
$59.65 M(-18.4%)
Jun 2024
-
$73.11 M(-18.5%)
Mar 2024
-
$89.66 M(-29.2%)
Dec 2023
$126.59 M(+325.5%)
$126.59 M(+107.6%)
Sep 2023
-
$60.97 M(+35.9%)
Jun 2023
-
$44.88 M(-9.3%)
Mar 2023
-
$49.48 M(+66.3%)
Dec 2022
$29.75 M
$29.75 M(-40.0%)
Sep 2022
-
$49.55 M(-13.5%)
DateAnnualQuarterly
Jun 2022
-
$57.30 M(+24.5%)
Mar 2022
-
$46.00 M(-39.6%)
Dec 2021
$76.12 M(-58.1%)
$76.12 M(-53.2%)
Sep 2021
-
$162.75 M(-42.1%)
Jun 2021
-
$281.15 M(+196.2%)
Mar 2021
-
$94.91 M(-47.8%)
Dec 2020
$181.73 M(+100.7%)
$181.73 M(+186.5%)
Sep 2020
-
$63.43 M(-43.4%)
Jun 2020
-
$112.15 M(+23.9%)
Dec 2019
$90.55 M(+149.4%)
$90.55 M
Dec 2018
$36.31 M
-

FAQ

  • What is C4 Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for C4 Therapeutics?
  • What is C4 Therapeutics annual cash & cash equivalents year-on-year change?
  • What is C4 Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for C4 Therapeutics?
  • What is C4 Therapeutics quarterly cash and cash equivalents year-on-year change?

What is C4 Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of CCCC is $55.50 M

What is the all time high annual cash & cash equivalents for C4 Therapeutics?

C4 Therapeutics all-time high annual cash & cash equivalents is $181.73 M

What is C4 Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, CCCC annual cash & cash equivalents has changed by -$71.09 M (-56.16%)

What is C4 Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of CCCC is $55.50 M

What is the all time high quarterly cash and cash equivalents for C4 Therapeutics?

C4 Therapeutics all-time high quarterly cash and cash equivalents is $281.15 M

What is C4 Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, CCCC quarterly cash and cash equivalents has changed by -$4.15 M (-6.96%)